Article
From the Incretin System to the Entero–Pancreatico–Hepatico–Systemic Polyhormonal Metabolic Homeostasis Network
2026-07-28
Abstract excerpt
The remarkable evolution of incretin-based therapeutics from selective glucagon-like peptide-1 receptor agonists to dual, triple and emerging polyagonists has fundamentally expanded our understanding of metabolic regulation. Clinical trials have consistently demonstrated coordinated improvements in glycaemic control, hepatic steatosis, body composition, insulin sensitivity, cardiovascular and renal outcomes, infla...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- db1ef2c5-3bdc-5641-bdd1-df4b0fb100ad
- DOI
- 10.20944/preprints202607.2008.v1
